SETD2 and malignant mesothelioma: Genome-wide sequencing analyses of malignant mesotheliomas have revealed frequently observed genomic aberrations such as loss of function mutation and/or copy number alterations/deletion of BAP1, SETD2, CDKN2A, and NF2 [4,5,6].